...
首页> 外文期刊>Biometrical Journal >Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments
【24h】

Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments

机译:基于合并的生物标志物评估,评估经协变量调整后的诊断准确度

获取原文
获取原文并翻译 | 示例
           

摘要

There is a need for epidemiological and medical researchers to identify new biomarkers (biological markers) that are useful in determining exposure levels and/or for the purposes of disease detection. Often this process is stunted by high testing costs associated with evaluating new biomarkers. Traditionally, biomarker assessments are individually tested within a target population. Pooling has been proposed to help alleviate the testing costs, where pools are formed by combining several individual specimens. Methods for using pooled biomarker assessments to estimate discriminatory ability have been developed. However, all these procedures have failed to acknowledge confounding factors. In this paper, we propose a regression methodology based on pooled biomarker measurements that allow the assessment of the discriminatory ability of a biomarker of interest. In particular, we develop covariate-adjusted estimators of the receiver-operating characteristic curve, the area under the curve, and Youden's index. We establish the asymptotic properties of these estimators and develop inferential techniques that allow one to assess whether a biomarker is a good discriminator between cases and controls, while controlling for confounders. The finite sample performance of the proposed methodology is illustrated through simulation. We apply our methods to analyze myocardial infarction (MI) data, with the goal of determining whether the pro-inflammatory cytokine interleukin-6 is a good predictor of MI after controlling for the subjects' cholesterol levels.
机译:流行病学和医学研究人员需要确定新的生物标志物(生物标志物),这些标志物可用于确定暴露水平和/或用于疾病检测。通常,与评估新生物标记物相关的高昂测试成本阻碍了这一过程。传统上,生物标志物评估是在目标人群中进行单独测试的。已提出合并以帮助降低测试成本的方法,合并多个单独的样本即可形成合并池。已经开发出使用合并的生物标志物评估来估计歧视能力的方法。但是,所有这些过程都未能认识到混杂因素。在本文中,我们提出了一种基于合并生物标记测量值的回归方法,该方法可以评估感兴趣的生物标记的区分能力。特别是,我们开发了接收者操作特征曲线,曲线下面积和尤登指数的协变量调整估计量。我们建立了这些估计量的渐近性质,并开发了推论性技术,使人们能够评估生物标记物是否是区分病例和对照的良好标志物,同时还能控制混杂因素。通过仿真说明了所提出方法的有限样本性能。我们应用我们的方法来分析心肌梗塞(MI)数据,以在控制受试者的胆固醇水平后确定促炎性细胞因子白介素6是否是MI的良好预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号